You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 HLA Typing Results from Patients 1 and 2

From: Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

HLA Class I A B Bw C Cw    
Patient 1 24:XX 07:XX 06:XX 04:XX 04:XX    
29:XX 35:XX 06:XX 07:XX 07:XX    
Patient 2 11:01 27:05 04:XX 01:02     
24:02 35:01 06:XX 04:01     
HLA Class II DRB1 DRB3 DRB4 DRB5 DQB1 DQA1 DPB1 DRw
Patient 1 04:XX   01:XX 01:XX 03:XX    53:XX
15:XX     05:XX    51:XX
Patient 2 01:01   01:03   03:02 01:01 03:01  
04:04   53:XX   05:01 03:01 14:01